EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Multi‐Omics and Machine Learning‐Uncovered FLT1 ‐Mediated Epithelial‐Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy

Mouyuan Sun iD, Huchao Mao, Yaxian Luo, Mei Yang, Zhixu He, Shuangyang Li, Zhichao Liu, Lianjie Peng, Quanjie Zhang, Jingyu Zhang, Yan Zhang

The FASEB Journal · 30.04.2026 · 40 (8)

DOI: 10.1096/fj.202503291rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 18.04.2026. Verfasst von Mouyuan Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Machine Learning, Carcinoma, Renal Cell, Cellular Senescence, Kidney Neoplasms. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is distinguished by the absence of definitive diagnostic markers and efficacious treatment modalities, factors that collectively contribute to its unfavorable clinical prognosis. The targeting of senescent cells has recently emerged as a promising therapeutic strategy. Nevertheless, the precise role of cellular senescence in the pathophysiology of ccRCC has yet to be comprehensively elucidated. This study sought to investigate the role of cellular senescence levels in ccRCC through comprehensive transcriptomic, proteomic, spatial transcriptomic, and single‐cell analyses. The study determined that elevated levels of cellular senescence contribute to a suppressed immune microenvironment, thereby exacerbating the prognosis for ccRCC patients. We utilized an extensive array of machine learning algorithms, in conjunction with multi‐omics technologies, validated through immunofluorescence, RT‐qPCR, and additional techniques, to collectively identify FLT1 as a pivotal single gene driving ccRCC progression. Our work reveals a FLT1‐centered network of related factors, where FLT1 acts as the core single gene, closely associated with key factors VEGFA and AKT1. This network mediates crosstalk between endothelial and epithelial cells: endothelial cells expressing FLT1 alone, AKT1 alone, or co‐expressing FLT1/AKT1 exhibited enhanced malignancy; among epithelial cells, proximal tubular epithelial cells with high VEGFA expression (a factor closely related to FLT1) represented the most aggressive subtype and acted as “pioneer cells” driving tumor progression. This FLT1‐centric mechanism is evolutionarily conserved, as validated in mouse single‐cell datasets. Clinically, ccRCC patients with low expression of the FLT1‐centered network (particularly low FLT1) showed better responses to immunotherapy. For patients with high FLT1 expression, a combination therapy targeting this network—screened via molecular docking and dynamics simulations—may improve prognosis. This includes FLT1 inhibitors (Sorafenib, Regorafenib, Lenvatinib), supplemented by AKT1 inhibitors (Capivasertib) and VEGFA inhibitors (Bevacizumab) to suppress FLT1‐associated malignant cell populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningCarcinoma, Renal CellCellular SenescenceKidney NeoplasmsVascular Endothelial Growth Factor Receptor-1Epithelial CellsEndothelial CellsHumansMultiomicsAnimalsGene Expression Regulation, NeoplasticVascular Endothelial Growth Factor ACell Line, TumorProto-Oncogene Proteins c-aktMiceProteomics

Stichwörter der Autor:innen

VEGFA/FLT1/AKT1 axiscellular senescenceclear cell renal cell carcinomaepithelial‐endothelial interactionmulti‐omics

Substanzen

Vascular Endothelial Growth Factor Receptor-1FLT1 protein, humanVascular Endothelial Growth Factor AProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou, China.
  • Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Mouyuan Sun

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Sun, M., Mao, H., Luo, Y., Yang, M., He, Z., Li, S., Liu, Z., Peng, L., Zhang, Q., Zhang, J., & Zhang, Y. (2026). Multi‐Omics and Machine Learning‐Uncovered FLT1 ‐Mediated Epithelial‐Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy. The FASEB Journal, 40(8). https://doi.org/10.1096/fj.202503291rr

Vancouver

Sun M, Mao H, Luo Y, Yang M, He Z, Li S, et al. Multi‐Omics and Machine Learning‐Uncovered FLT1 ‐Mediated Epithelial‐Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy. The FASEB Journal. 2026;40(8). doi:10.1096/fj.202503291rr

BibTeX
@article{Sun2026,
  author = {Sun, Mouyuan and Mao, Huchao and Luo, Yaxian and Yang, Mei and He, Zhixu and Li, Shuangyang and Liu, Zhichao and Peng, Lianjie and Zhang, Quanjie and Zhang, Jingyu and Zhang, Yan},
  title = {Multi‐Omics and Machine Learning‐Uncovered FLT1 ‐Mediated Epithelial‐Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1096/fj.202503291rr}
}
Kostenlos starten →